Gilead Sciences Inc (NASDAQ:GILD) Raises Dividend
Gilead Sciences Inc (NASDAQ:GILD) stock rose 5.65% (As on February 11, 11:25:56 AM UTC-4, Source: Google Finance) after the company logged higher profit in its…
Posts Tagged: NASDAQ:GILD
Gilead Sciences Inc (NASDAQ:GILD) Raises FY25 Guidance
Gilead Sciences Inc (NASDAQ:GILD), a leading biopharmaceutical company specializing in antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, stock…
Gilead Sciences Inc (NASDAQ:GILD) Tops Analysts’ Expectations
Gilead Sciences Inc (NASDAQ:GILD) stock rose 7.69% (As on February 12, 11:28:01 AM UTC-4, Source: Google Finance) after the company reported fourth quarter results that…
Gilead Sciences, Inc. (NASDAQ:GILD) Beat Wall Street Expectations
Gilead Sciences, Inc. (NASDAQ:GILD) stock rose 5.71% (As on November 7, 10:25:56 AM UTC-4, Source: Google Finance) after the company reported third-quarter financial results that handily…
Gilead Sciences, Inc. (NASDAQ:GILD) Topline Grows 5%
Gilead Sciences, Inc. (NASDAQ:GILD) stock fell 2.61% (As on August 9, 11:20:43 AM UTC-4, Source: Google Finance) after the company posted better than expected results…
Gilead Sciences, Inc. (NASDAQ:GILD) Upgraded To Outperform
Gilead Sciences, Inc. (NASDAQ:GILD) stock fell 0.97% (As on July 9, 11:18:10 AM UTC-4, Source: Google Finance) after Raymond James analyst Steven Seedhouse upgraded the…
Gilead Sciences, Inc. (NASDAQ:GILD) Misses Analysts’ Estimates
Gilead Sciences, Inc. (NASDAQ:GILD) stock fell 3.63% (As on February 7, 11:40:17 AM UTC-4, Source: Google Finance) after the company reported fourth-quarter earnings that missed…
Gilead Sciences, Inc. (NASDAQ:GILD) Posts Flat Revenue
Gilead Sciences, Inc. (NASDAQ:GILD) stock fell 3.19% (As on November 8, 11:16:32 AM UTC-4, Source: Google Finance) after the company beat Street estimates as lower…